CoChat

Increased BDNF methylation in saliva, but not blood, of patients with borderline personality disorder

Open access

The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The importance of epigenetic alterations in psychiatric disorders is increasingly acknowledged and the use of DNA methylation patterns as markers of disease is a topic of ongoing investigation. Recent studies suggest that patients suffering from Borderline Personality Disorder (BPD) display differential DNA methylation of various genes relevant for neuropsychiatric conditions. For example, several studies report differential methylation in the promoter region of the brain-derived neurotrophic factor gene (BDNF) in blood. However, little is known about BDNF methylation in other tissues. RESULTS: In the present study, we analyzed DNA methylation of the BDNF IV promoter in saliva and blood of 41 BPD patients and 41 matched healthy controls and found significant hypermethylation in the BPD patient's saliva, but not blood. Further, we report that BDNF methylation in saliva of BPD patients significantly decreased after a 12-week psychotherapeutic intervention. CONCLUSIONS: Providing a direct comparison of BDNF methylation in blood and saliva of the same individuals, our results demonstrate the importance of choice of tissue for the study of DNA methylation. In addition, they indicate a better suitability of saliva for the study of differential BDNF methylation in BPD patients. Further, our data appear to indicate a reversal of disease-specific alterations in BDNF methylation in response to psychotherapy, though further experiments are necessary to validate these results and determine the specificity of the effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13148-018-0544-6

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 a, b DNA methylation at the BDNF IV promoter in blood and saliva of BPD patients (T1) (N = 41 for saliva, N = 39 for blood) as compared to healthy controls (N = 41). Data shown for single CpG sites (a) and average methylation calculated over all analyzed CpG sites (b), error bars represent SEM. Three asterisks (***) indicate statistical significance at p value < 0.001. c Schematic drawing of the BDNF gene with exons 1–9. Analyzed CpG sites (marked in green) are within the exon IV promoter, in direct vicinity of the transcription start site (TSS)
Fig. 1 a, b DNA methylation at the BDNF IV promoter in blood and saliva of BPD patients (T1) (N = 41 for saliva, N = 39 for blood) as compared to healthy controls (N = 41). Data shown for single CpG sites (a) and average methylation calculated over all analyzed CpG sites (b), error bars represent SEM. Three asterisks (***) indicate statistical significance at p value < 0.001. c Schematic drawing of the BDNF gene with exons 1–9. Analyzed CpG sites (marked in green) are within the exon IV promoter, in direct vicinity of the transcription start site (TSS)CC BY · PubMed Central
Fig. 2 Correlation of methylation levels between blood and saliva DNA samples of BPD patients (N = 39) and healthy controls (N = 41). Regression lines are displayed separately for healthy controls and BPD patients
Fig. 2 Correlation of methylation levels between blood and saliva DNA samples of BPD patients (N = 39) and healthy controls (N = 41). Regression lines are displayed separately for healthy controls and BPD patientsCC BY · PubMed Central
Fig. 3 BDNF IV promoter methylation in BPD patients before and after a 12-week psychotherapeutic treatment in saliva (a–c, N = 26) and blood (d–f, N = 23). Data shown for single CpG sites (a, d) and for the average calculated from all analyzed CpG sites (b, c, e, f), Data points are displayed as mean ± SEM of all patients at the two time points. Statistical analysis has been conducted with paired t tests. Asterisks indicate significance p < 0.05 (a, b, d, e). Individual differences in DNA methylation levels before and after treatment shown for every patient in saliva (c) and blood (f)
Fig. 3 BDNF IV promoter methylation in BPD patients before and after a 12-week psychotherapeutic treatment in saliva (a–c, N = 26) and blood (d–f, N = 23). Data shown for single CpG sites (a, d) and for the average calculated from all analyzed CpG sites (b, c, e, f), Data points are displayed as mean ± SEM of all patients at the two time points. Statistical analysis has been conducted with paired t tests. Asterisks indicate significance p < 0.05 (a, b, d, e). Individual differences in DNA methylation levels before and after treatment shown for every patient in saliva (c) and blood (f)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 94 references

Research works printed but not linked: 1

  1. Franke GH. Symptom-Checkliste von L.R. Derogatis - Deutsche Version (SCL-90-R). Göttingen: Beltz Test; 2002.

Cited by

See all 56

Metadata

Authors
Thomas, M., Knoblich, N., Wallisch, A., Glowacz, K., Becker-Sadzio, J., Gundel, F., Brückmann, C., & Nieratschker, V.
Affiliations
Universitätsklinikum Tübingen (DE)
Corresponding author
Nieratschker, Vanessa
Venue
Clinical Epigenetics
Published
2018-08-22
Volume
10
Issue
1
Pages
109-109
ISSN
  • 1868-7075 (ISSN-L)
  • 1868-7083
OpenAlex
W2888265828
Cited by
51
References
94
Citations by year
2026: 3 · 2025: 6 · 2024: 8 · 2023: 9 · 2022: 9 · 2021: 4 · 2020: 6 · 2019: 6
FWCI
1.42
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • Clinical Epigenetics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Brain and Behavior Research Foundation (23949)
  • Medizinischen Fakultät, Eberhard Karls Universität Tübingen (PK2015-1-11)
  • Wilhelm-Schuler-Stiftung
  • Studienstiftung des Deutschen Volkes
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
  • Social Sciences › Psychology › Clinical Psychology › Psychopathy, Forensic Psychiatry, Sexual Offending
Keywords
borderline personality disorder, brain-derived neurotrophic factor, DNA methylation, saliva, blood, epigenetics, psychotherapy, promoter hypermethylation, biomarkers, tissue comparison
MeSH terms
Adult, Borderline Personality Disorder, Female, Humans, Male, Promoter Regions, Genetic, Saliva, Biomarkers, Case-Control Studies, Treatment Outcome, CpG Islands, DNA Methylation, Brain-Derived Neurotrophic Factor, Epigenesis, Genetic, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased BDNF methylation in saliva, but not blood, of patients with borderline personality disorder. https://app.cochat.ai/papers/10.1186/s13148-018-0544-6
The paper
Thomas, M., Knoblich, N., Wallisch, A., Glowacz, K., Becker-Sadzio, J., Gundel, F., Brückmann, C., & Nieratschker, V. (2018). Increased BDNF methylation in saliva, but not blood, of patients with borderline personality disorder. Clinical Epigenetics. https://doi.org/10.1186/s13148-018-0544-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.